Lophos Holdings Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jacqueline Lupo
Chief executive officer
CA$217.4k
Total compensation
CEO salary percentage | 57.0% |
CEO tenure | 2.4yrs |
CEO ownership | 3.5% |
Management average tenure | no data |
Board average tenure | 1.5yrs |
Recent management updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -CA$1m |
Jun 30 2023 | n/a | n/a | -CA$1m |
Mar 31 2023 | CA$217k | CA$124k | -CA$988k |
Compensation vs Market: Jacqueline's total compensation ($USD158.56K) is about average for companies of similar size in the Canadian market ($USD175.62K).
Compensation vs Earnings: Insufficient data to compare Jacqueline's compensation with company performance.
CEO
Jacqueline Lupo (36 yo)
2.4yrs
Tenure
CA$217,433
Compensation
Ms. Jacqueline Claire Lupo is CEO & Director of Lophos Holdings Inc. and serves as Director since December 23, 2021 and has been its President. She is the CEO of Lophos Pharmaceuticals Corp. She studied Ce...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 2.4yrs | CA$217.43k | 3.49% CA$ 165.0k | |
Independent Director | 1.5yrs | no data | no data | |
Director | 1.5yrs | no data | 0.00088% CA$ 41.6 | |
Director | less than a year | no data | no data |
1.5yrs
Average Tenure
43yo
Average Age
Experienced Board: MESC's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.